What is Eton Pharmaceuticals, Inc.'s stock issuance proceeds?

Eton Pharmaceuticals, Inc. (ETON) reported stock issuance proceeds of $1.39M in Q1 2026.

How has Eton Pharmaceuticals, Inc.'s stock issuance proceeds changed year-over-year?

Eton Pharmaceuticals, Inc.'s stock issuance proceeds increased by 252.5% year-over-year, from $394K to $1.39M.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Eton Pharmaceuticals, Inc. ETON Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

HRO

HarrowHROW

$25K+8.7%

Zevra Therapeutics, Inc.ZVRA

$752K—

XER

Xeris Biopharma Holdings, Inc.XERS

$847K-82.6%

ANI PharmaceuticalsANIP

$2.2M-13.1%

Crinetics PharmaceuticalsCRNX

$380.51M—

Catalyst PharmaceuticalCPRX

$3.3M—

Other financials

Income statement

See full

Revenue$24.3M+40.4%

Gross profit$14.7M+49.4%

Operating income$2.4M+614%

Net income$1.6M+199%

EPS (diluted)$0.05+183%

Balance sheet

See full

Cash & equivalents$19.7M+12.9%

Total debt$31.3M+3.7%

Total equity$30.6M+25.2%

Total assets$97.7M+16.3%

Cash flow

See full

Operating cash flow$7.4M+254%

CapEx$75.0K—

Free cash flow$7.3M+251%

Valuation

See full

Market cap$930.79M+156%

Enterprise value$942.39M+150%

P/S10.7×+3.2×

Profitability

See full

Gross margin54.8%-3.7pp

Operating margin-15.1%—

Net margin-9.5%-2.7pp

FCF margin17.1%—

Returns & leverage

See full

Return on equity-34.2%+0.9pp

Debt / equity1×-0.2×

Current ratio1.2×-0.8×

Where this comes from

Reported directly by Eton Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockPlans.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s stock issuance proceeds?: Eton Pharmaceuticals, Inc. (ETON) reported stock issuance proceeds of $1.39M in Q1 2026.
How has Eton Pharmaceuticals, Inc.'s stock issuance proceeds changed year-over-year?: Eton Pharmaceuticals, Inc.'s stock issuance proceeds increased by 252.5% year-over-year, from $394K to $1.39M.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.